Kezdőlap・Részvénylista・GE HealthCare Technologies

GE HealthCare Technologies

Lezárt

SzektorEgészségügy

70.25 0.75

Vétel Eladás

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

68.98

Maximum

70.34

Fő mutatók
By Trading Economics
Bevétel	163M 574M
Értékesítés	164M 5.3B
P/E Szektor átlag	16.067 68.51
Egy részvényre jutó nyereség	1.13
Osztalékhozam	0.21
Profit margin	10.84
Munkavállalók	54,000
EBITDA	52M 807M

Ajánlások
By TipRanks
Ajánlások	Vétel
12 hónapos előrejelzés	+12.54% upside

Osztalékok
By Acuity
Osztalékhozam Szektor átlag	0.21% 2.29%
Következő eredményjelentés	2026. okt. 28.
Következő osztalékfizetési dátum	2026. aug. 14.
Következő korábbi osztalék dátum	2026. okt. 23.

Piaci statisztika
By TradingEconomics
Piaci kapitalizáció	3.9B 32B
Előző nyitás	69.5
Előző zárás	70.25

Hangulat hírek alapján

By Acuity

92%

10 / 340 Rangsor szerint Healthcare

GE HealthCare Technologies Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 4. 23:41 UTC

Shares of GE Healthcare Technologies are trading higher in after-market hours, reflecting unusual activity and remaining above the 20-day moving average.

2026. aug. 3. 23:01 UTC

Shares of GE Healthcare Technologies declined after-market, continuing a downward trend since Monday's close amid broader market conditions.

2026. júl. 31. 23:16 UTC

News

Shares of GE Healthcare Technologies are lower in after-market trading following UBS's Neutral rating and a price target increase to $73.

2026. júl. 30. 22:31 UTC

News

GE Healthcare Technologies reported Q2 revenue of $5.30 billion, but shares are trading lower after highlighting challenges in the Patient Care Solutions segment.

2026. júl. 29. 23:21 UTC

GE Healthcare shares are lower in after-market hours, reflecting a decline after briefly recovering earlier in the session. No specific news was identified.

2026. júl. 28. 23:41 UTC

GE Healthcare Technologies Inc. shares are higher in after-market trading, showing volatility with no specific news identified to explain the movement.

2026. júl. 27. 23:16 UTC

GE Healthcare shares are trading higher in after-market hours, reflecting a modest increase since Monday's close amid positive sentiment in European markets.

2026. júl. 24. 20:03 UTC

Event

News

GE Healthcare shares decline as CFO Jay Saccaro steps down amid preliminary Q2 results showing revenue growth to $5.295 billion.

2026. júl. 23. 23:41 UTC

Event

News

GE Healthcare appointed George Newcomb as interim CFO and reported $5.30 billion in second-quarter revenue, with shares higher in after-market trading.

2026. júl. 22. 23:31 UTC

GE Healthcare Technologies shares moved higher in after-market trading, despite earlier fluctuations. Broader market dynamics include rising crude oil prices amid U.S.-Iran tensions.

2026. júl. 21. 23:46 UTC

GE Healthcare shares are higher in after-market hours amid positive market sentiment from recent earnings reports, though they remain below the 20-day moving average.

2026. júl. 20. 16:31 UTC

News

GE Healthcare Technologies has launched MIM Anyware, enhancing remote access to its software portfolio. Shares are trading higher, breaking from a recent upward trend.

Társak összehasonlítása

Árváltozás

GE HealthCare Technologies Előrejelzés

Célár

By TipRanks

12.54% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 79.07 USD 12.54%

Magas 92 USD

Alacsony 70 USD

14 Wall Street elemző 12 hónapos célárain alapulva a(z)GE HealthCare Technologies termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

14 ratings

Vétel

Tartás

Eladás

14 Wall Street elemző célárain alapulva a(z)GE HealthCare Technologies termékhez az elmúlt 3 hónapban.

Hangulat

By Acuity

10 / 340 Rangsor szerint Egészségügy

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

Rólunk GE HealthCare Technologies

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.